Bukwang Pharmaceutic...
KOSE:A003000
7.660,00
+ ₩490,00 (6,83%)
7.660,00
+₩490,00 (6,83%)
End-of-day quote: 04/24/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

₩389,00
Earnings Per Share
₩2,08k
Revenue Per Share
46,27%
Gross Margin %
₩755,77 B
Market Cap
₩79,02 B
Long-Term Debt
Earnings Per Share
₩389,00
Revenue Per Share
₩2,08k
Gross Margin %
46,27%
Market Cap
₩755,77 B
Long-Term Debt
₩79,02 B

Financials

Year Year 2026 2025 2024 2023 2015 2012
EPS Earnings Per Share ₩389,00 ₩389,00 ₩389,00 ₩389,00 ₩245,82
Earnings Earnings ₩40,03B ₩26,63B ₩26,63B ₩25,13B ₩13,53B
RPS Revenue Per Share ₩0,00 ₩1,38k ₩2,08k ₩2,08k ₩2,20k ₩0,00
Revenue Revenue ₩0,00M ₩142,13B ₩142,13B ₩142,13B ₩142,13B ₩0,00M
OCF Operating Cash Flow ₩0,00M ₩10,30B ₩10,30B ₩10,30B ₩10,30B ₩0,00M
FCF Free Cash Flow ₩0,00M ₩0,00M ₩0,00M ₩0,00M ₩5,72B ₩0,00M
OM Operating Margin 0,00% 7,06% 1,01% -29,78% 16,38% 14,53%
GM % Gross Margin % 0,00% 45,60% 46,27% 37,26% 58,04% 53,95%
FCFS Free Cash Flow Per Share ₩0,00 ₩124,31 ₩469,46 ₩-174,26 ₩94,90 ₩700,40
LT Debt Long-Term Debt N/A ₩79,02B ₩79,02B ₩78,53B N/A N/A
Sha. Stocks 68,45M 102,91M 68,45M 68,45M 64,59M 55,06M
×